SkinBioTherapeutics' technology, SkinBiotix®, shows positive results in cream formulation

SkinBioTherapeutics' technology, SkinBiotix®, shows positive results in cream formulation

Manchester, UK - 17 April 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, announces that the 'cream' formulation of its SkinBiotix® technology has passed effectiveness studies in models of skin. The cream formulation will now u...

17th April, 2018 Read More

MTA signed with global consumer goods company

MTA signed with global consumer goods company

Manchester, UK - 03 April 2018 - SkinBioTherapeutics plc (AIM: SBTX, the "Company"), a life science company focused on skin health, announces the signing of an MTA relating to its proprietary SkinBiotix® technology with a major, global consumer goods company. ...

3rd April, 2018 Read More

Global Group UK Investor Show

Global Group UK Investor Show

The Company will be exhibiting at the UK Investor Show in April. Free investor class tickets are available for the show on 21st April at the QEII Centre in Westminster. For free tickets please go to www.UKInvestorshow.com/tickets and use the code EXHIBIT....

28th March, 2018 Read More

Business Update

Business Update

Company CEO Cath O'Neill, caught up with Proactive's Andrew Scott following the release of the interim results....

1st March, 2018 Read More

DirectorsTalk Interview

DirectorsTalk Interview

Company CEO Cath O'Neill talks to DirectorsTalk about the progress made since FY results in October 17....

1st March, 2018 Read More

Half Year Results

Half Year Results

Manchester, UK - 21 February 2018 - SkinBioTherapeutics plc (AIM: SBTX or the "Company") a life sciences company focused on skin health, has announced its half year results for the six months to 31 December 2017....

21st February, 2018 Read More
investors logo